3 employees
Algonist Biotechnologies is a pre-clinical stage biotechnology company, developing novel small molecule therapeutics for chronic pain.
2020
Algonist Biotechnologies raised undisclosed on January 1, 2023
Investors: Kinled Holding Ltd